When 🇪🇺 gave conditional marketing approval to AstraZeneca on 29 Jan, the company informed EU it would not be meeting original dosage delivery promise because of production problems in EU plant. Seems doses to be reserved for 🇪🇺 had gone to 🇬🇧
— Dave Keating (@DaveKeating) March 19, 2021
The battle between EU & AZ began